# Predictive Value of Biomarkers of the Alzheimer's Disease (AD) in Elderly Patients With New-onset Epilepsy

> **NCT02861846** · NA · COMPLETED · sponsor: **Hospices Civils de Lyon** · enrollment: 35 (actual)

## Conditions studied

- Epilepsy

## Interventions

- **BIOLOGICAL:** profile of CSF biomarkers of AD

## Key facts

- **NCT ID:** NCT02861846
- **Lead sponsor:** Hospices Civils de Lyon
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-03-01
- **Primary completion:** 2023-03-16
- **Final completion:** 2023-03-16
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2023-03-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02861846

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02861846, "Predictive Value of Biomarkers of the Alzheimer's Disease (AD) in Elderly Patients With New-onset Epilepsy". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT02861846. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*